Korea
STRADVISION Surpasses 1 Million Units in Annual Production, Leading the Charge in Automotive Vision Technology
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- Building on the success of
its groundbreaking SVNet with 3D Perception Technology,STRADVISION
2024-02-27 00:00
1140
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.
* Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use inSouth Korea as an adjuvant cell therapy for the treatment of Hepatocellular Carcinoma (HCC) after curative resection and has receivedFDA Orphan Drug Designations (ODDs) for liver, brain...
2024-02-26 21:30
1021
SAPEON collaborates with DOCOMO Innovations for AI services enhancement
SAPEON collaborates with DOCOMO Innovations to conduct a PoC (Proof of Concept)
for providing AI services
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- SAPEON (CEO Soojung Ryu,
www.sapeon.com
2024-02-26 21:00
903
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024)
SEOUL, South Korea, Feb. 26, 2024 /PRNewswire/ -- J INTS BIO announced on the 26th of month that the Phase 1/2 clinical study of its Novel Oral 4th Generation EGFR TKI "JIN-A02" for the treatment of NSCLC has been accepted for poster presentation at the upcoming American Association for Cancer Re...
2024-02-26 16:15
1004
Flow Studio Takes Another Step Forward with CES 2024 Win
POHANG-SI, South Korea, Feb. 23, 2024 /PRNewswire/ -- Flow Studio
2024-02-23 22:00
1830
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease
PANGYO, South Korea, Feb. 23, 2024 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing of the first healthy participant in its first-in-human study of ADEL-Y01 for the treatment of Alzheimer's disease (AD). Oscotec and ADEL are jointly developing a novel disease-modifying immunothera...
2024-02-23 21:00
1758
AUTOCRYPT Launches Cybersecurity Testing Platform for UN R155/156 and GB Compliance
New platform enables automotive OEMs to conduct regulatory compliant security testing and share integrated results for vehicle type approval SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- Automotive cybersecurity company AUTOCRYPT announced the launch of AutoCrypt CSTP, a comprehensive cybers...
2024-02-20 22:00
1250
Integrit Unveils 'Stella': Pioneering AI Hardware Generating Dynamic Interactions with LLMs
SEOUL, South Korea, Feb. 20, 2024 /PRNewswire/ -- AI Robotics platform
specialist Integrit (Seoul/integrit.ai
2024-02-20 21:00
1615
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC
- A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint Inhibitor across multiple cancer types SEOUL, South Korea, Feb. ...
2024-02-16 22:03
2241
TelePIX Unveils TetraPLEX: A Breakthrough High-Performance AI Processor for Satellites
SEOUL, South Korea, Feb. 15, 2024 /PRNewswire/ -- TelePIX, a pioneering space startup based inSouth Korea, has achieved a groundbreaking feat: the development of TetraPLEX, a high-performance AI processor designed specifically for satellites. Boasting an impressive 10 trillion operations per seco...
2024-02-15 22:00
1395
STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus
SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ -- STARmed, a leading developer
and manufacturer of medical devices for tumor ablation, today announced global
market expansion of its EUSRA and ELRA products, throughOlympus
2024-02-14 22:00
863
Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods
- The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy - 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023 SEOUL, South K...
2024-02-14 21:00
1325
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024
* Recent updates on its development of LSD treatments were presented YONGIN, South Korea, Feb. 14, 2024 /PRNewswire/ -- GC Biopharma (CEO, Eun-Chul Huh), a South Korean biopharmaceutical company, announced onFeb. 14th that it has presented the development updates on its LSD (Lysosomal Storage D...
2024-02-14 16:33
1509
LG Energy Solution Strengthens Partnership with WesCEF, Secures Stable Lithium Supply Chain for the North American Market
* LG Energy Solution signs a second offtake agreement with WesCEF, expands its supply chain for competitive lithium procurement * Lithium hydroxide and lithium concentrate from WesCEF's Mt. Holland lithium project to be assembled into IRA-compliant batteries for the North American market * ...
2024-02-14 07:00
1430
STRADVISION Appoints Philip Vidal as Chief Business Officer to Drive Global Expansion
* Drawing from his roles at Motional and Tesla, Philip brings a wealth of
experience to his new position at STRADVISION SEOUL, South Korea, Feb. 12, 2024
/PRNewswire/ --STRADVISION
2024-02-13 00:00
1909
First in Human Dosed in Clinical Trial of ZMA001 for Treatment of Pulmonary Arterial Hypertension (PAH)
INCHEON, South Korea, Feb. 7, 2024 /PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for Pulmonary Arterial Hypertension (PAH) has been initiated. The placebo-controlled phase 1 trial designed to a...
2024-02-08 11:53
1327
GC Labs successfully concludes day2 of Medlab Middle East 2024
YONGIN, South Korea, Feb. 6, 2024 /PRNewswire/ -- GC Labs, a leading clinical
laboratory inSouth Korea, announced that the company concluded day2 with a
successful performance at the Medlab Middle East 2024.
2024-02-06 23:00
1420
Amorepacific Announces Positive Research Results of Fermented Ginseng in Skin Lymphatic Activation
Reveals potential improvement in lymphatic activation and skin health through fermented ginseng ingredients SEOUL, South Korea, Feb. 6, 2024 /PRNewswire/ -- Amorepacific, in collaboration with the School of Mechanical Engineering at Korea University, has unveiled groundbreaking research demonstr...
2024-02-06 22:00
1356
AXIS-Y Unveils Cheongdam Flagship Store: A New Era of Inclusive K-Beauty
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- In a groundbreaking move for the beauty industry, AXIS-Y, the Korean skincare pioneer known for its commitment to inclusivity, has not only spotlighted its diverse global team but also celebrated the opening of its flagship offline store in the vib...
2024-02-06 11:30
1258
AXIS-Y Marks a Remarkable 95% Sales Growth: Leading the Way in K-Beauty Innovation
SEOUL, South Korea, Feb. 5, 2024 /PRNewswire/ -- In an astonishing display of growth and innovation, AXIS-Y, a frontrunner in the K-beauty industry, has announced a staggering 95% increase in sales compared to the previous year. This milestone underscores the brand's formidable presence in the gl...
2024-02-06 11:06
1144
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 281 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 276 media titles]
2024-04-15 08:00
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3814
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3081
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
2972
